Pharmacological and Therapeutic Potential of Chamomile in Lowering Blood Triglyceride Levels: A Systematic Review and Meta-Analysis
Bibliographic record
Abstract
Background: Hypertriglyceridemia is a major risk factor for cardiovascular and metabolic disorders. Matricaria chamomilla (Chamomile), a widely used medicinal herb, possesses antioxidant, anti-inflammatory, and lipid-modulating properties. Its specific effects on serum triglyceride levels, however, remain to be systematically evaluated. Objective: This systematic review aims to comprehensively assess the pharmacological and therapeutic effects of Matricaria chamomilla on serum triglyceride levels across human, animal, and in vitro studies. Methods: A structured literature search was conducted in PubMed, Scopus, and Web of Science up to 2025. Studies evaluating Chamomile’s impact on triglyceride levels were included. Data extraction and quality assessment were independently performed by two reviewers using Cochrane Risk of Bias and Newcastle–Ottawa Scale tools. Findings were synthesized qualitatively, and meta-analysis was performed where appropriate. Results: Ten studies met inclusion criteria, including 4 human clinical trials, 4 animal studies, and 2 in vitro investigations. Chamomile consistently reduced serum triglyceride levels in animal models and showed moderate lipid-lowering effects in humans. Mechanistic evidence indicates its effects are mediated through antioxidant activity, modulation of lipid-metabolizing enzymes, and anti-inflammatory pathways. Reported adverse effects were minimal and mild. Conclusion: Current evidence supports Matricaria chamomilla as a potential adjunct therapy for hypertriglyceridemia. High-quality randomized controlled trials are needed to establish optimal dosing, treatment duration, and long-term safety.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.010 | 0.023 |
| Meta-epidemiology (narrow) | 0.003 | 0.001 |
| Meta-epidemiology (broad) | 0.019 | 0.034 |
| Bibliometrics | 0.007 | 0.008 |
| Science and technology studies | 0.001 | 0.001 |
| Scholarly communication | 0.003 | 0.002 |
| Open science | 0.002 | 0.001 |
| Research integrity | 0.002 | 0.002 |
| Insufficient payload (model declined to judge) | 0.005 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".